NIH-funded research R01 grant

Understanding how multiple health conditions affect medication in older adults

Official title: Evaluating the role of multimorbidity in modulation medication effects in older adults

Funded at Rutgers Biomedical and Health Sciences · NIH-11014351 · Data updated 2026-11-12

This study looks at how having more than one health issue affects how well medications work and their safety for older adults, with the hope of finding better ways to treat them based on their individual health needs.

More Multimorbidity research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startFebruary 1, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$618,605
NIH project number5R01HL163163-03
Project IDNIH-11014351 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults over 65 who are managing multiple chronic health conditions.

Less likely to help

Patients who are younger than 65 or do not have multiple chronic health conditions may not benefit from this research.

What this research studies

This research investigates how having multiple health conditions, known as multimorbidity, influences the effectiveness and safety of medications in older adults. By analyzing data from over 23 million Medicare patients, the study aims to identify how these co-existing conditions can change the benefits and risks associated with various cardiometabolic therapies. The goal is to develop better treatment strategies that consider the unique health profiles of older patients, ultimately improving medication outcomes for this population.

Why it matters

Potential benefit: If successful, this research could lead to more effective and safer medication regimens for older adults with multiple health conditions.

How similar studies have gone: Previous research has shown that understanding multimorbidity can significantly improve treatment outcomes, indicating that this approach has potential for success.

Where this research is happening

  • Rutgers Biomedical and Health Sciences
    Newark, United States
    Active

Researchers

  • Principal investigator: Dave, Chintan — Rutgers Biomedical and Health Sciences
  • Study coordinator: Dave, Chintan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.